XOMA ROYALTY CORPORATION

XOMANASDAQ

🏆 #2574 by market capEarnings Aug 12US Equity

$40.17▲ $0.00 (+0.00%)

Live

1h—

24h▲ 0.0%

7d▼ 0.4%

14d▼ 0.4%

30d▼ 0.4%

1y▲ 40.6%

🏦Market Cap

$504M

Small Cap

📈Revenue Growth (YoY)

+83.1%

High Growth

📊Gross Margin

93.3%

High

💵FCF Margin

18.3%

Healthy

⚖️P/S Ratio

13.9x

Elevated

Otter Score

Weak

Trading Snapshot

Day Range: $39.55 – $40.34
52-Week Range: $22.29 – $45.22
Volume: $2.13B
Avg Volume: $2.25B
Shares Outstanding: 12.5M
Next Earnings: Sep 8, 2026

Fundamentals Snapshot

Annual Revenue: $52M
Last Q Revenue: $12M
P/E Ratio: 24.3
P/S Ratio: 13.9x
EPS (TTM): $2.65
Dividend Yield: 0.00%

Why Investors Own XOMA

✓High-growth profile — revenue up +57.1% YoY with expanding US Equity exposure.
✓Healthy economics — 28% gross margin and 6% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$52M▲ +55.0% YoY

Gross Margin (TTM)

27.5%▼ −0.4% YoY

Operating Income (TTM)

$8M▲ +55.0% YoY

Free Cash Flow (TTM)

$3M▲ +55.0% YoY

About XOMA ROYALTY CORPORATION

XOMA Royalty Corp. functions as a specialist in aggregating biotechnology royalties, with its operations extending across Europe, the United States, and the Asia Pacific region. The company is dedicated to fostering advancements in human health by collaborating with biotechnology firms. Its core business model involves acquiring the anticipated future economic benefits, such as royalties and milestone payments, associated with pre-market therapeutic candidates that have already been licensed to pharmaceutical or biotechnology firms. The firm focuses its investments on early to mid-stage clinical assets, typically those in Phase 1 and 2 trials, selected for their robust commercial potential and because they are licensed to development partners. Its extensive portfolio currently encompasses around 70 distinct assets. The parent company, XOMA Corporation, established in 1981, has its main office in Emeryville, California.

🦦